Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect?

CorMedix (CRMD) closed the last trading session at $11.26, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19 indicates a 68.7% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $3.11. While the lowest estimate of $14.00 indicates a 24.3% increase from the current price level, the most optimistic analyst expects t ...